Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has announced a new research call, funded through the UK’s Global AMR Innovation Fund (GAMRIF), to identify and develop solutions that address the rising burden of antimicrobial resistance (AMR) in the environment.
The initiative focuses on delivering contextual solutions for low- and middle-income countries (LMICs) that are globally relevant and scalable. Up to £170,000 or Rs 2 crore will be awarded per startup, in addition to 360-degree ecosystem support including on-field testing and validation studies.
The C-CAMP Programme on AMR in the Environment (2025–26), Call #2, is looking for innovations that aim to address the unmet needs of AMR in the environment, across the three areas:
The C-CAMP Programme on AMR in the Environment (2025–26), Call #2 will accept solutions from India, as well as from non-Indian innovators with an Indian partner or Indian subsidiary, to encourage collaboration and generate context-specific innovations that can be scaled globally.
Welcoming the announcement of the new research call, Dr Taslimarif Saiyed, Director-CEO, C-CAMP said, “C-CAMP has been fostering innovations addressing AMR across human health, agriculture including animal health, and environment since the last decade or more. We have just concluded our first C-CAMP GAMRIF Challenge that focused exclusively on AMR in the environment, where we built an exciting cohort of nine technologies relevant to those in LMICs both in India and beyond. With this latest call, we aim to identify our second cohort and further strengthen the global pipeline of demonstrated, validated and commercially proven technologies. The effort is to create a robust body of deployable solutions to be tapped into anywhere in the world, particularly in LMICs, to stem AMR in the environment. We are looking forward to working with GAMRIF with the guidance of the Office of Principal Scientific Adviser to the Govt. of India.”
